Tyra Biosciences, Inc.
TYRA
$10.09
$0.020.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.07% | -6.47% | -28.41% | -2.80% | 20.32% |
| Total Depreciation and Amortization | -0.69% | 13.39% | 0.79% | 3.28% | 19.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.67% | -7.52% | 134.59% | -11.85% | -1.80% |
| Change in Net Operating Assets | -1,046.54% | 1,282.61% | -99.60% | 184.37% | -209.38% |
| Cash from Operations | -29.95% | -9.45% | -74.48% | 53.43% | -62.78% |
| Capital Expenditure | -133.33% | 88.46% | 88.94% | -245.59% | 77.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 360.08% | -67.77% | 114.95% | -893.68% | 112.66% |
| Cash from Investing | 360.28% | -67.72% | 114.87% | -902.25% | 112.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 209.77% | -4.98% | 19.07% | -99.69% | 61,777.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -48.52% | -- |
| Cash from Financing | 209.77% | -4.98% | 99.20% | -99.81% | 61,725.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 173.41% | -370.92% | 102.84% | -178.87% | 224.56% |